Zimmer Biomet Holdings Inc
NYSE:ZBH
Zimmer Biomet Holdings Inc
Revenue
Zimmer Biomet Holdings Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
Revenue
$7.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$16.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$42B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Zimmer Biomet Holdings Inc
Revenue Breakdown
Breakdown by Geography
Zimmer Biomet Holdings Inc
|
Total Revenue:
7.7B
USD
|
|
United States:
4.4B
USD
|
|
Others Countries:
3.2B
USD
|
Breakdown by Segments
Zimmer Biomet Holdings Inc
|
Total Revenue:
7.7B
USD
|
|
Knees:
3.2B
USD
|
|
Hips:
2B
USD
|
|
Set:
1.9B
USD
|
Zimmer Biomet Holdings Inc
Glance View
Zimmer Biomet Holdings Inc. stands as a prominent player in the medical device industry, specializing in musculoskeletal healthcare. Emerging from a rich legacy that dates back to its origins in the early 20th century, the company has carved out its niche by innovating in the orthopedic reconstruction sector. Zimmer Biomet operates primarily through designing, manufacturing, and marketing a comprehensive range of orthopedic products, which include joint replacement implants, such as knees, hips, and shoulders, as well as products used for fracture fixation and bone growth stimulation. The innovative edge of Zimmer Biomet lies in its commitment to improving patient outcomes and enhancing the quality of life through advanced surgical and robotic technologies. The company invests significantly in R&D to maintain its competitive edge, constantly pushing the boundaries in personalized solutions and minimally invasive surgery. The company generates revenue by selling its orthopedic and surgical products directly to hospitals, surgical centers, and healthcare providers worldwide. Zimmer Biomet's business model is heavily reliant on the relationships it builds with orthopedic surgeons and healthcare institutions, positioning itself as an essential partner in delivering sophisticated solutions for musculoskeletal health. By focusing on comprehensive, integrated solutions, Zimmer Biomet not only addresses the immediate surgical needs but also engages with the continuum of care in rehabilitation and patient recovery. The company’s strategic acquisitions, sophisticated product pipeline, and global market presence enable it to capture a significant share of the medical device market, ensuring its role as a stalwart in transforming the future of healthcare.
See Also
What is Zimmer Biomet Holdings Inc's Revenue?
Revenue
7.7B
USD
Based on the financial report for Dec 31, 2024, Zimmer Biomet Holdings Inc's Revenue amounts to 7.7B USD.
What is Zimmer Biomet Holdings Inc's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Zimmer Biomet Holdings Inc have been 4% over the past three years , -1% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet